Dosage and Administration

AGAMREE Is Dosed Once Daily1

  • The recommended dosage of AGAMREE is 6 mg/kg taken orally once daily, preferably with a meal, up to a maximum daily dosage of 300 mg for patients weighing >50 kg
    • Some patients may respond to a dose of 2 mg/kg/d; doses may be titrated down to 2 mg/kg/d as needed based on individual tolerability
  • Dosage modifications are recommended for patients with hepatic impairment or with concomitant use of strong CYP3A4 inhibitors. Please see full Prescribing Information

AGAMREE Is Available as a 40 mg/mL Oral Suspension1

Use the guide below to calculate the dose for your patient

Be sure to indicate the dose in mL on the prescription to help ensure accurate administration

Switching From Corticosteroid Treatment to AGAMREE1

  • Patients can be switched from oral corticosteroid treatment (eg, prednisone or deflazacort) to AGAMREE without treatment interruption or period of prior corticosteroid dosage reduction to minimize the risk for adrenal insufficiency
    • Based on available clinical trial data, a dosage of prednisone of 0.75 mg/kg/d (or corticosteroid equivalent) corresponds to AGAMREE 6 mg/kg/d

Access and Support

AGAMREE Access and Financial Support

Catalyst Pathways® offers your patients a world of personalized support

Catalyst Pathways provides intuitive programs and expert personnel to support patients with Duchenne muscular dystrophy (DMD) and their caregivers throughout their treatment journey.

Catalyst Pathways offers several programs to help with accessibility and affordability of AGAMREE for your patients

Catalyst Bridge Medicine Program

While your patients’ insurance coverage is being reviewed, Catalyst Pathways will provide qualifying patients with “Bridge” medicine (free medicine to span the gap between insurance investigation and confirmation of coverage).

Delivery Assurance Program

Catalyst Pharmaceuticals understands that AGAMREE can only help your patients if they can get their medication. Through the Catalyst Delivery Assurance program, they will. Our Delivery Assurance team members are constantly monitoring and anticipating all potential obstacles to delivery and are formulating alternate plans to ensure that your patients can always get their tablets. Whatever the threat—hurricane, tornado, earthquake, transit strike, or major sporting event—Catalyst will have a plan in place to assure AGAMREE delivery.

Financial Assistance

Catalyst Pathways offers an array of options, including a copay support program to reduce your patients’ out-of-pocket costs.

Our dedicated team of experts helps optimize your patients’ AGAMREE treatment experience

Care Coordinator

To provide a warm welcome into the Catalyst Pathways program and introduce patients to their dedicated team

Patient Access Liaison

Your patients’ go-to, local resource for one-on-one disease education, as well as support for treatment and insurance needs

Insurance Navigator

Personalized guidance to help your patients handle any complicated insurance and reimbursement issues that may arise

ENROLL YOUR PATIENTS NOW IN CATALYST PATHWAYS!

There are 2 easy ways to secure all the benefits of Catalyst Pathways:

Download and complete the

Enrollment Form

OR

Call 1-833-4-CATALYST
(1-833-422-8259) to talk with a
representative who can help you
complete the Enrollment Form

Find More Support

Discover everything Catalyst Pathways® has to offer you and your patients by visiting our dedicated website

Go to Website

Proven Efficacy
and Safety

View clinical trial results for the efficacy and safety of AGAMREE in boys with DMD

View Data